Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by WESPAC Advisors SoCal LLC

WESPAC Advisors SoCal LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% in the third quarter, Holdings Channel reports. The institutional investor owned 889 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. WESPAC Advisors SoCal LLC’s holdings in Intuitive Surgical were worth $437,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. LRI Investments LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. Finally, LGT Financial Advisors LLC lifted its position in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock valued at $45,897,071 over the last three months. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 1.9 %

Shares of ISRG opened at $527.61 on Friday. The firm’s fifty day simple moving average is $499.29 and its 200-day simple moving average is $457.89. The firm has a market capitalization of $187.92 billion, a price-to-earnings ratio of 84.82, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $295.02 and a twelve month high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on ISRG. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Stifel Nicolaus upped their price target on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.